title: Comment on pegylated liposomal Doxorubicin plus docetaxel in metastatic breast cancer.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Smith
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Hillner
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D011092:Polyethylene Glycols / Q000008:administration & dosage; D016019:Survival Analysis; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D043823:Taxoids; C506643:liposomal doxorubicin; D000077143:Docetaxel; D011092:Polyethylene Glycols; D004317:Doxorubicin